OARSI Seeks Candidates for Board Positions: OARSI is now accepting applications for the Board of Directors for a 4-year term beginning in April, 2024. Find out more here: https://oarsi.org/about-board-directors/nominations-policies-and-procedures … Twitter: Oarsi News
RT by @OARSInews: Prof. Ali Mobasheri starts with Proteomics, Metabolomics and Lipidomics as Molecular Biomarkers for the identification of endotypes in OA @OARSInews @SEReumatologia @girblanco1 #SEROARSI23 Twitter: Oarsi News
RT by @OARSInews: OARSI president Prof. Gu-il Im opening the SER-OARSI symposium: From Biomarkers to Precision Medicine. Welcome to A Coruña! @OARSInews @SEReumatologia @girblanco1 Twitter: Oarsi News
RT by @OACJournal: It's been a pleasure working with the editorial staff of OAC so far! A challenging and highly instructive experience, allowing me to work with authors to advance our research field. Keep submitting your best work and don't be… Twitter: OAC Journal
Meet the team 👋 We are privileged to have Jeroen Geurts as an Editorial Board Member at OAC 🤩 Read more about Jeroen's research interests and hobbies 🎾🏃🎶 ⤵️ Twitter: OAC Journal
RT by @OACJournal: New review available! An overview of effector molecules, cells, and cytokines in both local and systemic OA-associated inflammation. https://tinyurl.com/37yvtxwd Thank you @AnaEscribano7 @AstridRoover @SilviaMonteag - a team effort Twitter: OAC Journal
📣Meet our #OARSI ECI committee📣 2023 chairs: 🟢Armaghan Mahmoudian @curious_zan 🟢Jesse Charlton @JesseCharlton_ Along with: 🔵Matt Harkey @Harkey_MS 🔵Brooke Patterson @Knee_Howells 🔵Andrea Dell'isola @Andre_Dellisola Plus 3 new members - to be… Twitter: OARSI_ECI
Our #OARSI YI (young investigators) Twitter has had a name change to become @OARSI_ECI (early career investigators) - see the OARSI website for more info 👇 https://buff.ly/43QnvjJ Keep your 👀 out for introductions to the ECI committee in the coming… Twitter: OARSI_ECI
Registration | OARSI 2023 World Congress on Osteoarthritis. Registration is open again and you are encouraged to register today. The early bird registration rate is extended to February 24, 2023, at 11:59 PM ET! https://buff.ly/3IEJeTB Twitter: OARSI_ECI
Pamidronate is ineffective for inflammatory-like low back pain associated with Modic type 1 changes: a double-blind, randomised controlled trial. Osteoarthritis and Cartilage Open
Role of ACTN4 in Disulfidptosis-Mediated Intervertebral Disc Degeneration: Insights from Mendelian Randomization Analysis Osteoarthritis and Cartilage Open
CD5L is a potential negative regulator of chondrocyte apoptosis in osteoarthritis Osteoarthritis and Cartilage Open
Updated Prevalence of Radiographic and Symptomatic Hip Osteoarthritis: Findings from the Johnston County Health Study Osteoarthritis and Cartilage
Commentary on: Ten year follow-up of a randomized trial of autologous chondrocyte implantation versus alternative forms of surgical cartilage management in the knee (Snow M et al., <em>Osteoarthritis and Cartilage</em> 2026) Osteoarthritis and Cartilage
WEIGHT-BEARING LOCOMOTION MITIGATES THE PROGRESSION OF POST-TRAUMATIC KNEE OSTEOARTHRITIS IN MALE RODENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS Osteoarthritis and Cartilage
